106 related articles for article (PubMed ID: 5596505)
1. [Scleroderma. Etiopathogenetic and therapeutic considerations].
Carlesimo OA; Nini G; Santucci B
Minerva Dermatol; 1967 Jan; 42(1):1-11. PubMed ID: 5596505
[No Abstract] [Full Text] [Related]
2. [Effect of combined treatment with nicotinic acid and DMSO on microcirculatory disorders in systemic scleroderma].
Aliab'eva AP; Mach ES; Balabanova RM
Ter Arkh; 1978; 50(9):105-7. PubMed ID: 705639
[No Abstract] [Full Text] [Related]
3. [Trafuril reaction in scleroderma].
Urban J
Przegl Dermatol; 1976; (6 Suppl):367-9. PubMed ID: 1032188
[No Abstract] [Full Text] [Related]
4. [Therapeutic properties of xanthine nicotinate in the treatment of obliterating arteriopathies].
Tardito E; Azzolini A; De Cristofaro A; Papacharalambus D
Minerva Cardioangiol; 1972; 20(7):369-89. PubMed ID: 5050745
[No Abstract] [Full Text] [Related]
5. [On the circulation promoting treatment in parkinsonism].
Völler G
Hippokrates; 1969 May; 40(10):393-7. PubMed ID: 5803728
[No Abstract] [Full Text] [Related]
6. [Dimethylsulfoxide as a vehicle for vasoactive drugs in the treatment of systemic scleroderma].
Balabanova RM; Mach ES; Astakhova TA; Aliab'ev AP; Kritskova IN
Ter Arkh; 1982; 54(2):118-21. PubMed ID: 6918176
[No Abstract] [Full Text] [Related]
7. [Clinical studies on Juston].
Bornfleth GH; Lehrach F
Med Monatsschr; 1975 Jan; 29(1):22-4. PubMed ID: 1091842
[No Abstract] [Full Text] [Related]
8. [On the treatment of arteriosclerotic chorioretinopathy].
Zielinski HW
Klin Monbl Augenheilkd; 1968; 152(2):233-41. PubMed ID: 5673766
[No Abstract] [Full Text] [Related]
9. [On the treatment of cerebral nutrition disorders. A double blind study].
Kirchberger F; Kehl R; Gutmann W
Med Welt; 1969 Jul; 27():1542-6. PubMed ID: 4895204
[No Abstract] [Full Text] [Related]
10. [On the therapy of central and peripheral blood circulation disorders].
Weihrauch H
Hippokrates; 1967 Sep; 38(18):739-42. PubMed ID: 5610064
[No Abstract] [Full Text] [Related]
11. [Treatment of hearing disorders using Cosaldon retard].
Schwertdtfeger F
Dtsch Med J; 1971 Feb; 22(3):87-92. PubMed ID: 5540731
[No Abstract] [Full Text] [Related]
12. [Experiences in the treatment of peripheral circulatory disorders with 7-2-hydroxy-3-(N-2-hydroxyethyl-N-methalamino)-propyl-1,3-dimethylxanthine-pyridine-3-carboxylate (Complamin)].
Huber FB
Praxis; 1966 Aug; 55(34):950-9. PubMed ID: 6012637
[No Abstract] [Full Text] [Related]
13. [Characteristics of the course of scleroderma in diabetes mellitus].
Khamaganova IV
Sov Med; 1990; (2):72-6. PubMed ID: 2356535
[No Abstract] [Full Text] [Related]
14. [Contribution to the etiology and therapy of scleroderma].
Schmechel A
Dermatol Wochenschr; 1966 Nov; 152(47):1306-10. PubMed ID: 5978773
[No Abstract] [Full Text] [Related]
15. [On problems of treatment of ocular blood supply disorders].
Neumann L
Klin Monbl Augenheilkd; 1968; 153(3):409-17. PubMed ID: 5724139
[No Abstract] [Full Text] [Related]
16. [Treatment of acute and chronic circulatory disorders with special reference to complamine].
Athitakis KN
Med Monatsschr; 1966 Sep; 20(9):428-30. PubMed ID: 5975343
[No Abstract] [Full Text] [Related]
17. Cosaldon for vascular disorders?
Drug Ther Bull; 1972 Aug; 10(17):66-8. PubMed ID: 4570865
[No Abstract] [Full Text] [Related]
18. [Post-streptococcal edematous scleroderma with myocardial involvement (author's transl)].
Gire R; Guillot F; Dries F
Arch Fr Pediatr; 1981; 38(6):441-2. PubMed ID: 7294960
[No Abstract] [Full Text] [Related]
19. [Treatment of chronic-degenerative rheumatism with Dipyron].
Iravani J; Lindewirth HP; Schüler KG
Med Welt; 1967 Jun; 23():1458-60. PubMed ID: 5617428
[No Abstract] [Full Text] [Related]
20. [Effect of fibrinolysis activation on the peripheral blood circulation in occlusive vascular diseases].
Bielawiec M; Lukjan H
Med Monatsschr; 1971 Jul; 25(7):312-4. PubMed ID: 5563915
[No Abstract] [Full Text] [Related]
[Next] [New Search]
